Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 480+ page report, which features 237 figures and 267 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

Key Market Insights
 Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products
 The market landscape features a mix of both established players and new entrants; multiple biologics fill / finish service providers based in developed geographies have already adopted advanced fill / finish technologies
 Vials represent the most prominent form of packaging used for biopharmaceutical interventions; with increasing demand for self-administration devices, syringes have also garnered significant attention
 In fact, to acquire competencies across the value chain, stakeholders have actively invested in expanding their existing infrastructure and capabilities to cater to the evolving needs of both indigenous and international clients
 Over the past six years, the fill / finish services domain has also witnessed significant partnership activity, with companies building strategic business relationships to consolidate their positions in the market
 The outcome of consolidation is evident from our proprietary competitiveness analysis, based on several relevant parameters highlighting service and supplier strengths
 Presently, the installed global contract fill / finish capacity, across various geographies, is estimated to be over 17 million units (in term of packaging containers)
 The demand for contract fill / finish services for biologics is expected to increase in the coming years; it is likely that stakeholders will have to expand their respective capacities to ensure consistent supply
 We expect biopharmaceutical developers to continue to outsource their fill / finish operations in the short to mid-term, resulting in an annualized growth rate of more than 10%
 In the long-term, the projected opportunity is anticipated to be well distributed across various types of primary packaging, biological interventions and target disease indications

For more information, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for Outsourcing Biologics-related Operations
3.4. Introduction to Contract Manufacturing
3.5. Commonly Outsourced Operations in the Biopharmaceutical Industry
3.5.1. Biologics Fill / Finish Operations
3.6. Basic Guidelines for Selecting a Fill / Finish Service Provider
3.7. Advantages of Outsourcing Fill / Finish Services
3.8. Risks and Challenges of Outsourcing Fill / Finish Operations

4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Biologics Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill / Finish Facilities
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Additional Services Offered
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Type of Biologics Filled

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters

5.4. Competitiveness Analysis: Biologics Fill / Finish Service Providers in North America
5.4.1. Companies Offering Fill / Finish Services for Ampoules
5.4.2. Companies Offering Fill / Finish Services for Cartridges
5.4.3. Companies Offering Fill / Finish Services for Syringes
5.4.4. Companies Offering Fill / Finish Services for Vials

5.5. Competitiveness Analysis: Fill / Finish Service Providers in Europe
5.5.1. Companies Offering Fill / Finish Services for Ampoules
5.5.2. Companies Offering Fill / Finish Services for Cartridges
5.5.3. Companies Offering Fill / Finish Services for Syringes
5.5.4. Companies Offering Fill / Finish Services for Vials

5.6. Competitiveness Analysis: Fill / Finish Service Providers of Asia-Pacific
5.6.1. Companies Offering Fill / Finish Services for Ampoules
5.6.2. Companies Offering Fill / Finish Services for Cartridges
5.6.3. Companies Offering Fill / Finish Services for Syringes
5.6.4. Companies Offering Fill / Finish Services for Vials

6. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Advanced BioScience Laboratories (ABL)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments
6.2.4. Future Outlook

6.3. Albany Molecular Research (AMRI)
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Financial Information
6.3.4. Recent Developments
6.3.5. Future Outlook

6.4. BioPharma Solutions
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments
6.4.5. Future Outlook

6.5. BioReliance
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments
6.5.5. Future Outlook

6.6. Emergent BioSolutions
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments
6.6.5. Future Outlook

6.7. Patheon
6.7.1. Company Overview
6.7.2. Services Portfolio
6.7.3. Financial Information
6.7.4. Recent Developments
6.7.5. Future Outlook

7. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments
7.2.5. Future Outlook

7.3. IDT Biologika
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Recent Developments
7.3.4. Future Outlook

7.4. Lonza
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments
7.4.5. Future Outlook

7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.3. Recent Developments
7.5.4. Future Outlook

7.6. Vetter Pharma
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Recent Developments
7.6.4. Future Outlook

8. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
8.1. Chapter Overview
8.2. Biocon
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments
8.2.5. Future Outlook

8.3. ChemPartner
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Recent Developments
8.3.4. Future Outlook

8.4. LuinaBio
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Recent Developments
8.4.4. Future Outlook

8.5. Mycenax Biotech
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.3. Recent Developments
8.5.4. Future Outlook

8.6. Wuxi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments
8.6.4. Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill / Finish Service Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Type of Service
9.3.4. Analysis by Scale of Operation
9.3.5. Analysis by Type of Biologic
9.3.6. Analysis by Geographical Location
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Service Alliances and Supply Agreements: Analysis by Type of Service
9.3.9. Acquisitions and Mergers: Analysis by Type of Service

10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Biologics Fill / Finish Service Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging
10.2.4. Analysis by Type of Service
10.2.5. Analysis by Type of Biologic
10.2.6. Analysis by Type of Biologic and Scale of Operation
10.2.7. Analysis by Geographical Location
10.2.8. Most Active Players: Analysis by Type of Service and Type of Biologic
10.2.9. Expansions in North America: Analysis by Type of Service and Type of
Biologic
10.2.10. Expansions in Europe: Analysis by Type of Service and Type of Biologic
10.2.11. Expansions in Asia-Pacific: Analysis by Type of Service and Type of Biologic

11. CAPACITY ANALYSIS
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global Installed Fill / Finish Capacity (by Number of Units)
11.3.1. Analysis by Type of Packaging
11.3.2. Analysis by Size of Manufacturer
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill / Finish Facilities

11.4. Global Installed Fill / Finish Capacity (by Volume)
11.4.1. Analysis by Type of Packaging
11.4.2. Analysis by Size of Manufacturer
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill / Finish Facilities

11.5. Global Installed Fill / Finish Capacity for Ampoules (by Number of Units)
11.5.1 Analysis by Size of Manufacturer
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill / Finish Facilities

11.6. Global Installed Fill / Finish Capacity for Ampoules (by Volume)
11.6.1. Analysis by Size of Manufacturer
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill / Finish Facilities

11.7. Global Installed Fill / Finish Capacity for Cartridges (by Number of Units)
11.7.1. Analysis by Size of Manufacturer
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill / Finish Facilities

11.8. Global Installed Fill / Finish Capacity for Cartridges (by Volume)
11.8.1. Analysis by Size of Manufacturer
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill / Finish Facilities

11.9. Global Installed Fill / Finish Capacity for Syringes (by Number of Units)
11.9.1 Analysis by Size of Manufacturer
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill / Finish Facilities

11.10. Global Installed Fill / Finish Capacity for Syringes (by Volume)
11.10.1. Analysis by Size of Manufacturer
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill / Finish Facilities

11.11. Global Installed Fill / Finish Capacity for Vials (by Number of Units)
11.11.1 Analysis by Size of Manufacturer
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill / Finish Facilities

11.12. Global Installed Fill / Finish Capacity for Vials (by Volume)
11.12.1. Analysis by Size of Manufacturer
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill / Finish Facilities

11.13. Conclusion

12. DEMAND ANALYSIS
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Global Demand for Biologics Fill / Finish Services
12.3.1. Analysis by Type of Packaging
12.3.2. Analysis by Type of Biologic
12.3.3. Analysis by Therapeutic Area
12.3.4. Analysis by Geographical Location

12.4. Demand and Supply Analysis
13. BIOLOGICS MANUFACTURING AND FILL / FINISH: KEY PERFORMANCE INDICATORS
13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill / Finish: Types of Key Performance Indicators
13.2.1. Financial Indicators
13.2.1.1. Big Pharma Perspective
13.2.1.2. Contract Manufacturers’ Perspective


13.2.2. Process and Capability Indicators
13.2.2.1. Big Pharma Perspective
13.2.2.2. Contract Manufacturers’ Perspective

13.2.3. Market Reputation Indicators
13.2.3.1. Big Pharma Perspective
13.2.3.2. Contract Manufacturers’ Perspective

13.2.4. Other Important Performance Indicators
13.3.5. Conclusion

14. MARKET SIZING AND OPPORTUNITY ANALYSIS
14.1. Chapter Overview
14.2. Forecast Methodology
14.3. Overall Biologics Fill / Finish Services Market, 2019-2030
14.3.1. Biologics Fill / Finish Services Market, 2019-2030: Distribution by Type of Packaging
14.3.2. Biologics Fill / Finish Services Market, 2019-2030: Distribution by Scale of Operation
14.3.3. Biologics Fill / Finish Services Market, 2019-2030: Distribution by Type of Biologic
14.3.4. Biologics Fill / Finish Services Market, 2019-2030: Distribution by Therapeutic Area
14.3.5. Biologics Fill / Finish Services Market, 2019-2030: Distribution by Geographical Region
14.3.5.1 Biologics Fill / Finish Services Market in North America, 2019-2030: Distribution by Countries
14.3.5.2. Biologics Fill / Finish Services Market in North America, 2019-2030: Distribution by Type of Packaging
14.3.5.3. Biologics Fill / Finish Services Market in North America, 2019-2030: Distribution by Scale of Operation
14.3.5.4. Biologics Fill / Finish Services Market in North America, 2019-2030: Distribution by Type of Biologic
14.3.5.5. Biologics Fill / Finish Services Market in North America, 2019-2030: Distribution by Therapeutic Area
14.3.5.6. Biologics Fill / Finish Services Market in Europe, 2019-2030: Distribution by Countries
14.3.5.7. Biologics Fill / Finish Services Market in Europe, 2019-2030: Distribution by Type of Packaging
14.3.5.8. Biologics Fill / Finish Services Market in Europe, 2019-2030: Distribution by Scale of Operation
14.3.5.9. Biologics Fill / Finish Services Market in Europe, 2019-2030: Distribution by Type of Biologic
14.3.5.10. Biologics Fill / Finish Services Market in Europe, 2019-2030: Distribution by Therapeutic Area
14.3.5.11. Biologics Fill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Countries
14.3.5.12. Biologics Fill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Packaging
14.3.5.13. Biologics Fill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.3.5.14. Biologics Fill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.3.5.15. Biologics Fill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Therapeutic Area

14.4. Biologics Fill / Finish Services Market for Ampoules, 2019-2030
14.4.2. Biologics Fill / Finish Services Market for Ampoules, 2019-2030: Distribution by Scale of Operation
14.4.2. Biologics Fill / Finish Services Market for Ampoules, 2019-2030: Distribution by Type of Biologic
14.4.3. Biologics Fill / Finish Services Market for Ampoules, 2019-2030: Distribution by Therapeutic Area
14.4.4. Biologics Fill / Finish Services Market for Ampoules, 2019-2030: Distribution by Geographical Region
14.4.4.1. Biologics Fill / Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Scale of Operation
14.4.4.2. Biologics Fill / Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Type of Biologic
14.4.4.3. Biologics Fill / Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Therapeutic Area
14.4.4.4. Biologics Fill / Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Scale of Operation
14.4.4.5. Biologics Fill / Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Type of Biologic
14.4.4.6. Biologics Fill / Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Therapeutic Area
14.4.4.7. Biologics Fill / Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.4.4.8. Biologics Fill / Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.4.4.9. Biologics Fill / Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Therapeutic Area

14.5. Biologics Fill / Finish Services Market for Cartridges, 2019-2030
14.5.1. Biologics Fill / Finish Services Market for Cartridges, 2019-2030: Distribution by Scale of Operation
14.5.2. Biologics Fill / Finish Services Market for Cartridges, 2019-2030: Distribution by Type of Biologic
14.5.3. Biologics Fill / Finish Services Market for Cartridges, 2019-2030: Distribution by Therapeutic Area
14.5.4. Biologics Fill / Finish Services Market for Cartridges, 2019-2030: Distribution by Geographical Region
14.5.4.1. Biologics Fill / Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Scale of Operation
14.5.4.2. Biologics Fill / Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Type of Biologic
14.5.4.3. Biologics Fill / Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Therapeutic Area
14.5.4.4. Biologics Fill / Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Scale of Operation
14.5.4.5. Biologics Fill / Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Type of Biologic
14.5.4.6. Biologics Fill / Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Therapeutic Area
14.5.4.7. Biologics Fill / Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.5.4.8. Biologics Fill / Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.5.4.9. Biologics Fill / Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Therapeutic Area

14.6. Biologics Fill / Finish Services Market for Syringes, 2019-2030
14.6.1. Biologics Fill / Finish Services Market for Syringes, 2019-2030: Distribution by Scale of Operation
14.6.2. Biologics Fill / Finish Services Market for Syringes, 2019-2030: Distribution by Type of Biologic
14.6.3. Biologics Fill / Finish Services Market for Syringes, 2019-2030: Distribution by Therapeutic Area
14.6.4. Biologics Fill / Finish Services Market for Syringes, 2019-2030: Distribution by Geographical Region
14.6.4.1. Biologics Fill / Finish Services Market for Syringes in North America, 2019-2030: Distribution by Scale of Operation
14.6.4.2. Biologics Fill / Finish Services Market for Syringes in North America, 2019-2030: Distribution by Type of Biologic
14.6.4.3. Biologics Fill / Finish Services Market for Syringes in North America, 2019-2030: Distribution by Therapeutic Area
14.6.4.4. Biologics Fill / Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Scale of Operation
14.6.4.5. Biologics Fill / Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Type of Biologic
14.6.4.6. Biologics Fill / Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Therapeutic Area
14.6.4.7. Biologics Fill / Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.6.4.8. Biologics Fill / Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.6.4.9. Biologics Fill / Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Therapeutic Area

14.7. Biologics Fill / Finish Services Market for Vials, 2019-2030
14.7.1. Biologics Fill / Finish Services Market for Vials, 2019-2030: Distribution by Scale of Operation
14.7.2. Biologics Fill / Finish Services Market for Vials, 2019-2030: Distribution by Type of Biologic
14.7.3. Biologics Fill / Finish Services Market for Vials, 2019-2030: Distribution by Therapeutic Area
14.7.4. Biologics Fill / Finish Services Market for Vials, 2019-2030: Distribution by Geographical Region
14.7.4.1. Biologics Fill / Finish Services Market for Vials in North America, 2019-2030: Distribution by Scale of Operation
14.7.4.2. Biologics Fill / Finish Services Market for Vials in North America, 2019-2030: Distribution by Type of Biologic
14.7.4.3. Biologics Fill / Finish Services Market for Vials in North America, 2019-2030: Distribution by Therapeutic Area
14.7.4.4. Biologics Fill / Finish Services Market for Vials in Europe, 2019-2030: Distribution by Scale of Operation
14.7.4.5. Biologics Fill / Finish Services Market for Vials in Europe, 2019-2030: Distribution by Type of Biologic
14.7.4.6. Biologics Fill / Finish Services Market for Vials in Europe, 2019-2030: Distribution by Therapeutic Area
14.7.4.7. Biologics Fill / Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.7.4.8. Biologics Fill / Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.7.4.9. Biologics Fill / Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Therapeutic Area

15. FUTURE GROWTH OPPORTUNITIES
15.1. Chapter Overview
15.2. Growing Biopharmaceutical Pipeline
15.3. Increase in Outsourcing Fill / Finish Activities
15.4. Rising Focus on Self-Administration
15.5. Advances in Aseptic Fill / Finish Technologies
15.6. Growing Opportunities in the Asia-Pacific Region

16. CASE STUDY: ROBOTIC SYSTEMS IN FILL / FINISH OPERATIONS
16.1. Chapter Overview
16.2. Contract Service Providers: List of Fill / Finish Equipment
16.3. Role of Robotic Systems in Fill / Finish Operations
16.3.1. Types of Robots Used in Pharmaceutical Operations
16.3.2. Key Considerations for Selecting a Robotic System
16.3.3. Advantages of Robotic Systems
16.3.4. Disadvantages of Robotic Systems
16.4. Companies Providing Robots for Use in the Pharmaceutical Industry
16.5. Concluding Remarks

17. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS IN ASEPTIC FILL / FINISH OPERATIONS
17.1. Chapter Overview
17.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
17.2.1. Advantages of Ready-to-Use Packaging Components
17.2.2. Disadvantages of Ready-to-Use Packaging Components
17.3. Companies Providing Ready-to-Use Packaging Components
17.4. Concluding Remarks

18. CONCLUDING REMARKS
18.1. Chapter Overview
18.2. Key Takeaways

19. INTERVIEW TRANSCRIPTS
19.1 Chapter Overview
19.2 HALIX
19.2.1 Interview Transcript: Jos Vergeest, International Business Developer
19.3 IDT Biologika
19.3.1. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
19.4 oncomed manufacturing
19.4.1 Interview Transcript: Ales Sima, Business Development Manager
19.5. Syngene
19.5.1 Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]